WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that members of the Company’s senior management will present on Wednesday, January 13, at 10:00 a.m. PST at the J.P. Morgan 28th Annual Healthcare Conference taking place at the Westin St. Francis in San Francisco.
